Summit Therapeutics PLC (SMMT) — Free Cash Flow Generation Index
Summit Therapeutics PLC (SMMT) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $4.24 Million represents 1% of operating cash flow ($4.23 Million). Explore Summit Therapeutics PLC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Summit Therapeutics PLC Free Cash Flow Generation Index (2004–2016)
Historical FCF Generation Index trend for Summit Therapeutics PLC across 2 annual periods. For the full cash flow conversion analysis, see SMMT cash flow metrics.
Annual Free Cash Flow Generation for Summit Therapeutics PLC (2004–2016)
Year-by-year Free Cash Flow Generation Index for Summit Therapeutics PLC. Check Summit Therapeutics PLC total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.99x | $15.07 Million | $15.18 Million | $110.00K | ▼ -31.8% |
| 2004 | 1.46x | $43.30K | $29.74K | $13.18K | — |